IGM Biosciences Inc. (IGMS)
NASDAQ: IGMS
· Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 13, 2025, 3:59 PM
1.28
0.79%
After-hours: Aug 13, 2025, 06:49 PM EDT
IGM Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 145.05M | 2.68M | 2.68M | 2.92M | 2.91M | 2.1M | 2.13M | 1.85M | 1.67M | 1.59M | 1.07M | 697K | 366K | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.79M | 4.63M | 6.8M | 6.63M | 8.89M | 10.13M | 7.96M | 9M | 9.36M | 8.38M | 10.6M | 9.56M | 8.89M | 8.6M | 7.72M | 5.55M | 3.59M | 1.34M |
Gross Profit | 142.26M | -1.95M | -4.13M | -3.71M | -5.98M | -8.03M | -5.83M | -7.15M | -7.69M | -6.79M | -9.53M | -8.86M | -8.52M | -8.6M | -7.72M | -5.55M | -3.59M | -1.34M |
Operating Income | -27.85M | -209.5M | -208.58M | -234.72M | -237.09M | -253.94M | -263.46M | -254.61M | -248.36M | -239.37M | -227.96M | -222.37M | -206.06M | -185.57M | -165.32M | -139.38M | -115.74M | -96.41M |
Interest Income | 8.5M | 10.63M | 12.79M | 15.12M | 17.17M | 17.61M | 17.74M | 16.82M | 14.29M | 11.15M | 7.04M | 3.29M | 849K | 89K | 35K | 35K | n/a | n/a |
Pretax Income | -53.38M | -198.87M | -195.79M | -219.6M | -219.92M | -236.33M | -245.74M | -237.86M | -234.15M | -228.43M | -221.1M | -219.17M | -205.29M | -185.41M | -165.16M | -139.14M | -115.25M | -95.38M |
Net Income | -53.38M | -198.87M | -195.79M | -219.84M | -220.4M | -236.92M | -246.42M | -233.92M | -227.49M | -221.03M | -213.56M | -216M | -204.6M | -185.35M | -165.16M | -139.14M | -115.25M | -95.38M |
Selling & General & Admin | 48.76M | 50.92M | 50.41M | 51.53M | 45.27M | 47.61M | 50.07M | 50.11M | 50.27M | 49.66M | 49.73M | 49.63M | 46.97M | 43.24M | 38.3M | 31.93M | 26.66M | 22.39M |
Research & Development | 101.82M | 139.38M | 160.85M | 186.11M | 194.73M | 208.44M | 215.52M | 206.35M | 199.76M | 191.31M | 179.29M | 173.44M | 159.46M | 142.33M | 127.03M | 107.46M | 89.09M | 74.02M |
Other Expenses | 21.89M | 21.89M | n/a | n/a | n/a | n/a | n/a | -58K | -58K | 571K | 633K | 729K | 764K | 159K | 159K | 238K | 203K | 179K |
Operating Expenses | 172.46M | 212.18M | 211.26M | 237.64M | 240M | 256.05M | 265.59M | 256.46M | 250.03M | 240.97M | 229.03M | 223.07M | 206.43M | 185.57M | 165.32M | 139.38M | 115.74M | 96.41M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 172.9M | 212.18M | 211.26M | 237.64M | 240M | 256.05M | 265.59M | 256.46M | 250.03M | 240.97M | 229.03M | 223.07M | 206.43M | 185.57M | 165.32M | 139.38M | 115.74M | 96.41M |
Income Tax Expense | n/a | n/a | n/a | 242K | 482K | 591K | 678K | -3.94M | -6.66M | -7.4M | -7.54M | -3.17M | -691K | -62K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 61.46M | 61.16M | 60.51M | 60.66M | 60.43M | 60.11M | 59.83M | 59.58M | 45.12M | 44.47M | 44.24M | 44.03M | 43.92M | 33.84M | 33.78M | 33.44M | 33.37M | 33.33M |
Shares Outstanding (Diluted) | 61.75M | 61.16M | 60.51M | 60.66M | 60.43M | 60.11M | 59.83M | 59.58M | 45.12M | 44.47M | 44.24M | 44.03M | 43.92M | 33.84M | 33.78M | 33.44M | 33.37M | 33.33M |
EPS (Basic) | -0.89 | -3.27 | -3.24 | -3.64 | -3.67 | -4.31 | -4.81 | -4.89 | -5.11 | -5 | -5.2 | -5.61 | -5.67 | -5.51 | -4.93 | -4.22 | -3.56 | -3.02 |
EPS (Diluted) | -0.9 | -3.27 | -3.24 | -3.64 | -3.67 | -4.31 | -4.81 | -4.89 | -5.11 | -5 | -5.2 | -5.61 | -5.67 | -5.51 | -4.93 | -4.22 | -3.56 | -3.02 |
EBITDA | -31.3M | -178.4M | -199.47M | -225.78M | -228.2M | -245.15M | -255.18M | -246.61M | -241.11M | -232.86M | -221.88M | -216.89M | -200.99M | -180.54M | -160.84M | -135.89M | -113.1M | -94.94M |
EBIT | -38.67M | -187.61M | -208.58M | -234.72M | -237.09M | -253.94M | -263.46M | -254.61M | -248.36M | -239.37M | -227.96M | -222.37M | -206.06M | -185.57M | -165.32M | -139.38M | -115.74M | -96.41M |
Depreciation & Amortization | 7.37M | 9.21M | 9.11M | 8.94M | 8.89M | 8.79M | 8.28M | 9.32M | 9.68M | 10.04M | 10.6M | 9.56M | 8.89M | 8.6M | 7.72M | 5.86M | 4.15M | 2.15M |